Ketotifen in childhood asthma: a double-blind placebo controlled trial.
In a three week double-blind cross-over controlled trial in twenty asthmatic children, ketotifen (HC 20-511, 'Zaditen', Sandoz) showed no significant difference from placebo, although there was a consistent trend in favour of the active drug.
D001249:Asthma / Q000188:drug therapy*; D002648:Child; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D010880:Piperidines / Q000627:therapeutic use*; D010919:Placebos / Q000627:therapeutic use; D012129:Respiratory Function Tests; D013876:Thiophenes / Q000627:therapeutic use*
D010880:Piperidines; D010919:Placebos; D013876:Thiophenes